VBI Vaccines (VBIV)
(Delayed Data from NSDQ)
$0.58 USD
0.00 (0.00%)
Updated Mar 27, 2024 04:00 PM ET
After-Market: $0.58 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Cash flow Statements
Fiscal Year End for VBI Vaccines, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -113.30 | -69.75 | -46.23 | -54.81 |
Depreciation/Amortization & Depletion | NA | 3.77 | 4.83 | 3.22 | 2.20 |
Net Change from Assets/Liabilities | NA | -2.66 | 15.21 | -10.14 | -6.63 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 38.50 | 9.80 | 6.10 | 10.53 |
Net Cash From Operating Activities | NA | -73.70 | -39.91 | -47.05 | -48.71 |
Property & Equipment | NA | -4.34 | -2.00 | -1.00 | -3.67 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 25.15 | -25.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -4.34 | 23.16 | -26.00 | -3.67 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.01 | 33.38 | 124.33 | 40.25 |
Issuance (Repayment) of Debt | NA | 20.00 | 12.00 | 4.70 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.56 | -1.09 | -6.63 | -2.84 |
Net Cash from Financing Activities | NA | 19.45 | 44.29 | 122.39 | 37.42 |
Effect of Exchange Rate Changes | NA | -0.48 | 0.33 | 0.27 | -0.09 |
Net Change In Cash & Equivalents | NA | -59.07 | 27.87 | 49.61 | -15.06 |
Cash at Beginning of Period | NA | 121.69 | 93.83 | 44.21 | 59.27 |
Cash at End of Period | NA | 62.63 | 121.69 | 93.83 | 44.21 |
Diluted Net EPS | NA | -13.21 | -8.11 | -6.31 | -13.81 |
Fiscal Year End for VBI Vaccines, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -92.82 | -72.38 | -27.75 | -113.30 |
Depreciation/Amortization & Depletion | NA | 2.93 | 1.96 | 0.98 | 3.77 |
Net Change from Assets/Liabilities | NA | -11.15 | -9.21 | -4.05 | -2.66 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 52.22 | 38.76 | 9.17 | 38.50 |
Net Cash From Operating Activities | NA | -48.83 | -40.87 | -21.66 | -73.70 |
Property & Equipment | NA | -0.70 | -0.58 | -0.53 | -4.34 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -0.70 | -0.58 | -0.53 | -4.34 |
Uses of Funds
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 23.91 | 0.00 | 0.00 | 0.01 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 20.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -1.48 | 0.00 | 0.00 | -0.56 |
Net Cash from Financing Activities | NA | 22.43 | 0.00 | 0.00 | 19.45 |
Effect of Exchange Rate Changes | NA | -0.08 | -0.34 | -0.05 | -0.48 |
Net Change In Cash & Equivalents | NA | -27.18 | -41.79 | -22.24 | -59.07 |
Cash at Beginning of Period | NA | 62.63 | 62.63 | 62.63 | 121.69 |
Cash at End of Period | NA | 35.45 | 20.84 | 40.39 | 62.63 |
Diluted Net EPS | NA | -1.01 | -5.18 | -3.22 | -2.40 |